Health

Facing new risks
Food safety, air quality, endocrine disruptors, GMOs, working conditions, the fight against epidemics, drug evaluation: there are many topics on which the EU tries to coordinate the policies of EU member states to protect European citizens' health. In an aging Europe where the burden of chronic diseases is rising, how to ensure good health for all, while encouraging economic progress?
A vial of the Johnson & Johnson Janssen Covid-19 vaccine at a vaccination center in Chicago, Illinois, on March 5, 2021. Photo: Kamil Krzaczynski / AFP
A vial of the Johnson & Johnson Janssen ... […]

Clot questions over J&J and AstraZeneca vaccines

The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
A sign reading 'Special hygiene measures - UK Mutant', referring to the B117 Covid strain, in an intensive care unit (ICU) at the hospital in Freising, southern Germany on April 12, 2021. Photo: Lennart Preiss / AFP
A sign reading 'Special hygiene measures... […]

Pandemic hits ‘critical point’ as Europe deaths top one million

Europe has passed the grim milestone of one million coronavirus deaths, as the WHO warned that infections are rising exponentially despite widespread efforts aimed at stopping them
Based on the most recent data, someone getting the AstraZeneca vaccine stands a 1-in-153,000 chance of cerebral venous sinus thrombosis (CVST). Photo: Martin Bureau / AFP
Based on the most recent data, someone g... […]

AstraZeneca vaccine: what we know and what we don’t

A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
Load More
Fail to load posts. Try to refresh page.